Direct Oral Anticoagulants (DOACs) Vs. Low Molecular Weight Heparins (LMWH) for Venous Thromboembolism (VTE) in Patients with Primary Brain Tumors or Secondary Brain Metastases

被引：1
|
作者：
Lee, Angela
Oley, Frank, Jr.
Lo, Mimi
Fong, Richard
McGann, Mary
Saunders, Ila
Block, Shanna
Mahajan, Anjlee
Pon, Tiffany
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-138635
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Use of Low Molecular Weight Heparin (LMWH) in Thrombocytopenic Patients with Hematologic Malignancy-Associated Venous Thromboembolism (VTE)
    Khanal, Nabin
    Bociek, R. Gregory
    Chen, Baojiang
    Vose, Julie M.
    Armitage, James O.
    Bierman, Philip J.
    Maness, Lori J.
    Lunning, Matthew A.
    Gundabolu, Krishna
    Bhatt, Vijaya R.
    BLOOD, 2015, 126 (23)
  • [32] SAFETY OF DIRECT ORAL ANTICOAGULANTS (DOACS) VS STANDARD OF CARE (SOC) IN CANCER PATIENTS WITH CATHETER ASSOCIATED VENOUS THROMBOEMBOLISM.
    Kulasekaran, Monika
    Latif, Hira
    Anandakrishnan, Ravi
    Niyongere, Sandrine
    Brar, Arshdeep
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 : E59 - E60
  • [33] Direct oral anticoagulants vs. low-molecular-weight heparin for pulmonary embolism in patients with glioblastoma
    Daniel Dubinski
    Sae-Yeon Won
    Martin Voss
    Fee Keil
    Wolfgang Miesbach
    Bedjan Behmanesh
    Max Dosch
    Peter Baumgarten
    Joshua D. Bernstock
    Volker Seifert
    Thomas M. Freiman
    Florian Gessler
    Neurosurgical Review, 2022, 45 : 451 - 457
  • [34] Direct oral anticoagulants vs. low-molecular-weight heparin for pulmonary embolism in patients with glioblastoma
    Dubinski, Daniel
    Won, Sae-Yeon
    Voss, Martin
    Keil, Fee
    Miesbach, Wolfgang
    Behmanesh, Bedjan
    Dosch, Max
    Baumgarten, Peter
    Bernstock, Joshua D.
    Seifert, Volker
    Freiman, Thomas M.
    Gessler, Florian
    NEUROSURGICAL REVIEW, 2022, 45 (01) : 451 - 457
  • [35] Direct oral anticoagulants versus low-molecular-weight heparins for the treatment of acute venous thromboembolism in patients with gastrointestinal cancer: a systematic review and meta-analysis
    Rungjirajittranon, Tarinee
    Owattanapanich, Weerapat
    Chinthammitr, Yingyong
    Ruchutrakool, Theera
    Suwanawiboon, Bundarika
    THROMBOSIS JOURNAL, 2022, 20 (01)
  • [36] Direct oral anticoagulants versus low-molecular-weight heparins for the treatment of acute venous thromboembolism in patients with gastrointestinal cancer: a systematic review and meta-analysis
    Tarinee Rungjirajittranon
    Weerapat Owattanapanich
    Yingyong Chinthammitr
    Theera Ruchutrakool
    Bundarika Suwanawiboon
    Thrombosis Journal, 20
  • [37] Direct Oral Anticoagulants vs Low-Molecular-Weight Heparin and Recurrent VTE in Patients With Cancer A Randomized Clinical Trial
    Schrag, Deborah
    Uno, Hajime
    Rosovsky, Rachel
    Rutherford, Cynthia
    Sanfilippo, Kristen
    Villano, John L.
    Drescher, Monic
    Jayaram, Nagesh
    Holmes, Chris
    Feldman, Lawrence
    Zattra, Ottavia
    Farrar-Muir, Haley
    Cronin, Christine
    Basch, Ethan
    Weiss, Anna
    Connors, Jean M.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 329 (22): : 1924 - 1933
  • [38] Efficacy and safety of direct oral anticoagulants vs. low molecular weight heparin for cancer-related venous thromboembolism: a meta-analysis of randomized trials
    Elbadawi, Ayman
    Shnoda, Mina
    Mahmoud, Karim
    Elgendy, Islam Y.
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2021, 7 (05) : 380 - 388
  • [39] Real World Data on Efficacy and Safety of Low-Dose Direct Oral Anticoagulants (DOACs) for Venous Thromboembolism (VTE) Prophylaxis in Newly Diagnosed Multiple Myeloma
    Basali, Diana
    Zureigat, Hadil
    Nurse, Daniel
    Elmaleh, Hassan
    Batah, Heya
    Adcock, Bridget
    Jia, Xuefei
    Wei, Wei
    Valent, Jason
    Anwer, Faiz
    Raza, Shahzad
    Samaras, Christy
    Khouri, Jack
    Williams, Louis
    van Heeckeren, Willem
    Mazzoni, Sandra
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S102 - S102
  • [40] The Risk of Major Bleeding with Low-Molecular-Weight-Heparins for Venous Thromboembolism in Dialysis Patients: The Q-VTE Study
    Klil-Drori, Adi J.
    Coulombe, Janie
    Nessim, Sharon J.
    Tagalakis, Vicky
    BLOOD, 2016, 128 (22)
12345